Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» clinical trials
clinical trials
Praxis share price halved after essential tremor fail, but biotech still plans phase 3
Praxis share price halved after essential tremor fail, but biotech still plans phase 3
Fierce Biotech
Praxis Precision Medicines
clinical trials
essential tremors
ulixacaltamide
Flag link:
Spotlight – What is next in Nash
Spotlight – What is next in Nash
EP Vantage
NASH
clinical trials
89Bio
Arrowhead Pharmaceuticals
Can-Fite BioPharma
Ewopharma
Hepagene Therapeutics
JNJ
Ligand Pharmaceuticals
Madrigal Pharmaceuticals
Merck
NGM Biopharmaceuticals
NorthSea Therapeutics
Novartis
Sagimet Biosciences
Terns Pharmaceuticals
Viking Therapeutics
Flag link:
Bristol Myers, J&J plan tests of new blood thinner in nearly 50,000 patients
Bristol Myers, J&J plan tests of new blood thinner in nearly 50,000 patients
BioPharma Dive
Bristol Myers Squibb
JNJ
clinical trials
Librexia
bloodthinners
Flag link:
Atom Bioscience reports positive Phase IIa chronic gout therapy trial data
Atom Bioscience reports positive Phase IIa chronic gout therapy trial data
Clinical Trials Arena
Atom Bioscience
gout
clinical trials
ABP-671
Flag link:
Atea dumps dengue drug as 'unevaluable' endpoint causes timelines, forecast costs to spiral
Atea dumps dengue drug as 'unevaluable' endpoint causes timelines, forecast costs to spiral
Fierce Biotech
Atea Pharmaceuticals
dengue
clinical trials
AT-752
Flag link:
Aldeyra reports positive data from dry eye disease therapy trial
Aldeyra reports positive data from dry eye disease therapy trial
Clinical Trials Arena
Aldeyra Therapeutics
clinical trials
reproxalap
dry eye disease
Flag link:
CSL's Phase 3 Study Shows First-In-Class Garadacimab Provides Patients with Significant HAE Attack Prevention with Monthly Dosing
CSL's Phase 3 Study Shows First-In-Class Garadacimab Provides Patients with Significant HAE Attack Prevention with Monthly Dosing
Drugs.com
CSL
clinical trials
garadacimab
HAE
Flag link:
23andMe doses first patient in ph2a anti-tumour monotherapy
23andMe doses first patient in ph2a anti-tumour monotherapy
Pharmaphorum
23andMe
clinical trials
solid tumors
23ME-00610
Flag link:
Merck reports two Phase 3 study misses for Keytruda
Merck reports two Phase 3 study misses for Keytruda
BioPharma Dive
Merck
clinical trials
Keytruda
prostate cancer
lung cancer
Flag link:
Acumen reveals late-stage clinical trial plans in early Alzheimer’s disease
Acumen reveals late-stage clinical trial plans in early Alzheimer’s disease
Clinical Trials Arena
Acumen Pharmaceuticals
clinical trials
Alzheimer's disease
ACU193
monoclonal antibodies
Flag link:
Junshi's lipid lowering drug hits phase 3 goals, teeing up challenge to Amgen, Sanofi in growth market
Junshi's lipid lowering drug hits phase 3 goals, teeing up challenge to Amgen, Sanofi in growth market
Fierce Biotech
Junshi Biosciences
Amgen
Sanofi
China
clinical trials
PCSK9 inhibitors
Flag link:
Axsome says FDA wants more data for Alzheimer’s agitation label expansion, but readout to come sooner
Axsome says FDA wants more data for Alzheimer’s agitation label expansion, but readout to come sooner
Endpoints
Axsome Therapeutics
FDA
clinical trials
Alzheimer's disease agitation
Alzheimer's disease
AXS-05
Flag link:
Amid fentanyl crisis, first-of-its-kind study to evaluate expanded methadone access
Amid fentanyl crisis, first-of-its-kind study to evaluate expanded methadone access
Stat
clinical trials
methadone
Fentanyl
opioids
Flag link:
Fulcrum's clinical hold caps off tough week for sickle cell drug development
Fulcrum's clinical hold caps off tough week for sickle cell drug development
Fierce Biotech
Fulcrum Therapeuticsl
FDA
sickle cell disease
clinical trials
FDX-6058
Novartis
Sangamo
Graphite Bio
Flag link:
Nektar's bitter pill: Phase 2 fail ends Lilly-partnered lupus program and prompts eczema rethink
Nektar's bitter pill: Phase 2 fail ends Lilly-partnered lupus program and prompts eczema rethink
Fierce Biotech
Nektar Therapeutics
rezpegaldesleukin
clinical trials
lupus
Flag link:
BioCryst hits another hurdle, delays trial for its 1 remaining clinical candidate
BioCryst hits another hurdle, delays trial for its 1 remaining clinical candidate
Fierce Biotech
Biocryst
BCX10013
complement-mediated diseases
clinical trials
Flag link:
Astellas Presents Update on Recently Cleared Pompe Gene Therapy Trial
Astellas Presents Update on Recently Cleared Pompe Gene Therapy Trial
BioSpace
Astellas
Pompe disease
clinical trials
AT845
Flag link:
Gilead Sciences reports positive data from HIV therapy trial
Gilead Sciences reports positive data from HIV therapy trial
Clinical Trials Arena
Gilead Sciences
lenacapavir
HIV
clinical trials
Flag link:
Merck’s COVID-19 treatment falls short in prevention study
Merck’s COVID-19 treatment falls short in prevention study
BioPharma Dive
Merck
COVID-19
Lagevrio
clinical trials
Flag link:
Aileron Terminates Phase 1b Breast Cancer Chemoprotection Trial Of ALRN-6924
Aileron Terminates Phase 1b Breast Cancer Chemoprotection Trial Of ALRN-6924
NASDAQ
Aileron Therapeutics
clinical trials
breast cancer
ALRN-6924
Flag link:
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »